NEWPORT BEACH, Calif., March 21, 2017 -- Dr. Tom Tooma of NVISION Eye Centers announced today that it is the first practice in Orange County to offer ReLEx® SMILE minimally-invasive laser vision correction. With over 600,000 procedures performed worldwide year to date, ReLEx SMILE is a proven procedure for treatment of myopia or nearsightedness. Only recently, however, was this revolutionary procedure FDA approved to be performed in the U.S.
ReLEx SMILE is the first minimally-invasive laser vision correction procedure available anywhere in the world. This revolutionary procedure developed by ZEISS utilizes the VisuMax® femtosecond laser to create a thin, disc-shaped lenticule within the cornea and a small incision on the surface of the cornea through which the lenticule is subsequently removed by the surgeon. The VisuMax femtosecond laser, which NVISION Eye Centers acquired in February, is the only laser that can currently perform the ReLEx SMILE procedure. With this new treatment option, NVISION Eye Centers, Newport Beach is now offering patients access to the newest, most advanced refractive laser vision correction technology currently available.
“The SMILE procedure is good news for some people who have previously been told they do not qualify for laser eye surgery,“ says Dr. Tom Tooma, founder of NVISION Eye Centers. “Our patients have been benefitting from this innovative procedure in our NVISION Eye Center locations in Toronto for a number of years. The addition of SMILE in Newport Beach helps us to provide the best possible visual result for every lifestyle.”
For more information, call (877) 455-9942 or visit: http://www.nvisioncenters.com.
ABOUT NVISION EYE CENTERS: NVISION Eye Centers is the premier provider of LASIK and cataract surgery in the U.S., with centers in California, Nevada, Oregon, Arizona and Toronto, Canada. An innovative leader in ophthalmology, NVISION is dedicated to providing the best patient experience through the use of the latest technology and treatment by the most talented and experienced surgeons in the industry. NVISION was founded in 2010 by Tom Tooma, M.D., one of the earliest pioneers of LASIK who has performed more than 120,000 procedures throughout his esteemed career. With more than 2,000 eye doctors referring their patients and trusting their own eyes to NVISION surgeons, NVISION Eye Centers is the Eye Doctors' #1 Choice®. For more information, visit www.NVISIONCenters.com or call (877) 455-9942.


Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Instagram Outage Disrupts Thousands of U.S. Users
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 



